Quality control in tissue engineering

<p>The rapid development in the multidisciplinary field of <a href="/facts/Tissue_engineering/Tx77KG1S">tissue engineering</a> has resulted in a variety of new and innovative medicinal products, often carrying living cells, intended to repair, regenerate or replace damaged human tissue. Tissue engineered medicinal products (TEMPs) vary in terms of the type and origin of cells and the product’s complexity. As all <a href="/facts/Medicinal_drug/h9mhwWP2">medicinal products</a>, the safety and efficacy of TEMPs must be consistent throughout the manufacturing process. <a href="/facts/Quality_control/lnXbvqvp">Quality control</a> and assurance are of paramount importance and products are constantly assessed throughout the manufacturing process to ensure their safety, efficacy, consistency and reproducibility between batches. The <a href="/facts/European_Medicines_Agency/h9FTtCYc">European Medicines Agency (EMA)</a> is responsible for the development, assessment and supervision of medicines in the EU. The <a href="/facts/European_Medicines_Agency/h9FTtCYc">appointed committees</a> are involved in referral procedures concerning safety or the balance of benefit/risk of a medicinal product. In addition, the committees organize inspections with regards to the conditions under which medicinal products are being manufactured. For example, the compliance with <a href="/facts/Good_manufacturing_practice/s4sETf1y">good manufacturing practice (GMP)</a>, <a href="/facts/Good_clinical_practice/8b9gcE2h">good clinical practice (GCP)</a>, <a href="/facts/Good_laboratory_practice/DXV9HLej">good laboratory practice (GLP)</a> and <a href="/facts/Pharmacovigilance/4v2PDxCM">pharmacovigilance (PhV)</a>.
</p>

Quality control in tissue engineering open-in-new

Quality control in tissue engineering